Efficacy and safety of topical siRNA-based formulation targeting DKK-1 in androgenetic alopecia: A randomized, double-blind, vehicle-controlled trial

Study limitation reported by the research below: “The study design tag 'Randomized Controlled Trial' and level of evidence '2' are inferred from the trial description in the title, not confirmed from full-text methods.”